Sentences with phrase «first treatment phase»
After the fourth writing session, which constituted the end of the first treatment phase, the short form of the WAI (WAI - S) was administered.
http://www.jmir.org/ Not exact matches
Phoundry enhances Intarcia's internal efforts to build upon the differentiated clinical success of its Phase 3 investigational therapy, ITCA 650, the first injection - free GLP - 1 therapy with the potential to deliver up to a full year of treatment from a single placement.
Cambridge, MA — March 30, 2017 — Aura Biosciences, a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells using viral nanoparticle conjugates, announced today that it has enrolled and dosed the first patient in its Phase 1b clinical trial of light - activated AU - 011, an investigational, first - in - class targeted therapy in development for the treatment of ocular melanoma, a rare and life - threatening disease.
«As for the so - called sublingual and epicutaneous immunotherapy, which is treatment under the tongue or on the skin, respectively, the first few trial phases have already achieved some success.
In phase I trials, researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase I / II clinical trial results reported at the American Society for Clinical Oncology (ASCO) Annual Meeting 2015 show promising results for investigational drug brigatinib against ALK + non-small cell lung cancer (NSCLC), with 58 of 78 ALK + patients responding to treatment, including 50 of 70 patients who had progressed after previous treatment with crizotinib, the first licensed ALK inhibitor.
The first - of - its - kind study found the dual treatments to be safe and elicit a clinical response in patients, according to new results from a phase I trial to be presented at the AACR Annual Meeting 2015 on April 19.
Pembrolizumab is set to become a new option for first line treatment of patients with advanced lung cancer and high PD - L1 expression, according to the results of the phase III KEYNOTE - 024 trial presented at the ESMO 2016 Congress in Copenhagen and published in the New England Journal of Medicine.
«First - line immunotherapy treatment can improve survival for subset of lung cancer patients: Results of phase III global clinical trial show that 75 percent of stage IV lung cancer patients with both complex tumor mutations and PDL - 1 positive status respond to nivolumab.»
This study is the first phase of a larger initiative to develop and pilot test Critical Time Intervention, a transitional assistance model for individuals leaving residential substance abuse treatment.
Those who had received T - sol in the blinded phase also continued to improve, suggesting that T - sol treatment efficacy does not plateau in the first few months.
Abadir and colleagues first tested 5 percent topical losartan on mice in three different phases of wound healing: group 1 treatment, for up to three days post-wound infliction to target the inflammatory phase; group 2 treatment, starting on day seven after wound infliction to target the proliferative / remodeling (later) phase of tissue healing; and group 3 treatment, starting the first day of wound infliction until closure to treat all wound healing phases.
A Phase 3 Open - Label Randomized Study of Quizartinib (AC220) Monotherapy Versus Salvage Chemotherapy in Subjects with FLT3 - ITD Positive Acute Myeloid Leukemia (AML) Refractory To or Relapsed After First - line Treatment With or Without Hematopoietic Stem Cell Transplantation (HSCT) Consolidation
The phase II portion enrolled 49 patients with untreated MDS / CMML / AML of any age receiving first salvage treatment for AML with a FLT3 - ITD mutation.
A novel targeted approach to the treatment of Hemophagocytic Lymphohistiocytosis (HLH) with an anti-interferon gamma (IFNγ) monoclonal antibody (mAb), NI - 0501: first results from a pilot phase 2 study in children with primary HLH
San Diego, January 8, 2015 — ViaCyte, Inc., a privately - held regenerative medicine company with the first stem cell - derived islet replacement therapy for the treatment of diabetes in clinical trials, has received a No Objection Letter from Health Canada providing clearance to proceed with sites in Canada for the Company's Phase 1/2 clinical trial of its VC - 01TM product candidate.
ViaCyte's VC - 01 ™ product candidate, a first - in - class cell replacement therapy for the treatment of type 1 diabetes, is currently being evaluated in a Phase 1/2 trial called STEP ONE, or Safety, Tolerability, and Efficacy of VC - 01 Combination Product in Type One Diabetes.
Clinical Trials Research and Billing First in Human / Early Phase PET in Oncology Case - Based Dose Reduction in Pediatric Nuclear Medicine: Practical and Necessary Radioiodine Therapy for Hyperthyroidism: The State of the Art Spondylodiscitis: Role of Imaging for Diagnosis and Monitoring Treatment Response Current Status and Future Prospects: PET and SPECT Instrumentation Alternative Payment Models and Value - Based Health Care: Nuts and Bolts Maximal Tolerated Activity of Radioactive Iodine for Metastatic Thyroid Cancer Teaching Old Radiopharmaceuticals New Tricks Intraoperative Detection Devices and Probes Molecular Imaging of Lung Inflammation Standardization of Advanced PET / SPECT Data Acquisition and Analysis Thyroid Cancer Management: Novel Therapeutics and Management Options Targeting Radionuclide Therapy in Various Non-Malignant Arthritic Conditions Using Radiosynoviorthesis (RSO) Are You Prepared for a Radiation Accident?
Phase 1 clinical trials are used in patients for whom conventional treatment has not worked, providing access to pivotal first - in - children, early - stage clinical trials with novel treatments before they are widely available.
«Patients in Phase I clinical studies are the first to potentially benefit from a new treatment,» said Cohn, a leading expert in the study and treatment of neuroblastoma, a malignant solid tumor that forms in the nervous system outside the brain.
Interim phase II results [12] of first treatment with electroporation of IL - 12 in 28 patients with advanced melanoma, after 24 weeks of treatment, reported at the American Society of Clinical Oncology 2014 Annual Meeting, revealed a 32.2 % objective response rate (ORR; the primary endpoint), with a CR in 10.7 %.
In September 2016, we announced the first clinical application of our GLAAS discovery platform in Sanofi's Phase 1 clinical trial evaluating a novel therapeutic candidate for the treatment of peanut allergy.
The drug, a monoclonal antibody called ipilimumab, is the first treatment of any kind ever shown in a large, randomized phase III clinical study (study MDX010 - 20) to improve overall survival in patients with metastatic melanoma who no longer respond to standard therapy.
GENYO is the first national centre devoted to genomics that integrates the Public Administration, the University and the biotechnology and pharmaceutical business sector, which would allow the integration of research in all its phases, from the generation of knowledge to its development in clinical and pharmaceutical applications, the development of new projects and services for the prevention, diagnosis and treatment of diseases associated to human genetic variability, such a cancer and rare diseases, diabetes, hypertension or degenerative diseases, among others.
The first - of - its - kind study found the dual treatments to be safe and elicit a clinical response in patients, according to new results from a phase I trial to be presented at the AACR Annual Meeting 2015 on Sunday, April 19 (Abstract #CT137).
For example, if you get symptoms of hyperthyroidism in the first phase, your treatment may include medicines to slow down the heart rate.
There are two phases of antibiotic treatment: the first phase quickly clears the most serious or «acute» infection from the body.
Home / NEWS & MEDIA / Pfizer Animal Health and American Humane Association Conclude First Phase of Study Evaluating the Benefits of Animal - Assisted Therapy for Children Undergoing Cancer Treatment
The first phase of treatment for uncomplicated diabetes is called regulation.
Pfizer Animal Health and American Humane Association Conclude First Phase of Study Evaluating the Benefits of Animal - Assisted Therapy for Children Undergoing Cancer Treatment
In the first post discussing the process of injury claims, we discussed the treatment phase.
Like Basham and Miehls, Fisch recommends utilizing a three - phase treatment approach, in which the first task is to establish safety, stabilization, and symptom reduction.
If patients were still suitable for the trial after the self - monitoring phase, they met with a clinician (other than the assessor) who informed them about their allocation and conducted the first session of their respective treatment condition.
An attachment - based model of «parental alienation» also establishes clear treatment parameters based on a fundamental understanding of the psychological processes involved, which require as the first step the child's protective separation from the pathogenic parenting of the narcissistic / (borderline) parent during the active phase of the child's treatment and recovery.
The first step in treating attachment - based «parental alienation» is to protectively separate the child from the source of the pathogenic parenting during the active phase of the child's treatment and recovery.
During the first phase of treatment, homework consists of a daily 5 - minute parent - child play interaction (called child - directed interaction, or CDI) in which the parent practices the relationship enhancement skills.
The first phase is Client History and Treatment Planning during which the therapist assesses the clinical landscape, evaluates the client's readiness for memory processing, and develops a treatmTreatment Planning during which the therapist assesses the clinical landscape, evaluates the client's readiness for memory processing, and develops a treatmenttreatment plan.
Techniques are taught within a phase - oriented treatment approach, focusing first on stabilization and symptom reduction.
The designers also completed the room in two phases — first choosing the upholstery, window treatments, rug, and one work of art, then introducing accessories and lamps later.